Ligand Pharmaceuticals Incorporated Development Agreements
2 Contracts & Agreements
- Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals Incorporated and Palvella Therapeutics, Inc (Filed With SEC on February 28, 2019)
- AMENDMENT NO. 2 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on November 9, 2009)
